alphad2 amlod2
Name
alzh2
Label
Acetylcholine Esterase Inhibitors For Alzheimers (SHHS2)
Description

Participant taking ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
ALZH2 Alzheimers
Acetylcholine Esterase Inhibitors For Alzheimers (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,587 -
Yes - 33 -
Unknown - 460 -
Acetylcholine Esterase Inhibitors For Alzheimers (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 176 647 1,146 1,042 539 37 3,587
Yes - - 2 14 14 3 33
Unknown 8 60 173 144 71 4 460
Acetylcholine Esterase Inhibitors For Alzheimers (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,644 1,943 3,587
Yes 17 16 33
Unknown 200 260 460
Acetylcholine Esterase Inhibitors For Alzheimers (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,133 239 215 3,587
Yes 29 3 1 33
Unknown 425 14 21 460